STOK
#2057
Stoke Therapeutics, Inc. - Common Stock
29.5 0 USD
+0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.27%
Monthly Change
-2.74%
6 month change
+0.27%
Year Change
+149.37%
Previous Close
29.1 3
Open
29.3 2
Low
29.2 7
High
29.5 0
Volume
129
Financials
- Market Capitalization 1.84 B
- Employee 170
- Founded 2014
- CEO N/A
- Website www.stoketherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00JPCBPG9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-11.59
Price to sales ratio
60.23
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2050 |  BCAX Bicara Therapeutics Inc. - Common Stock | 28.09 USD | -0.04% | -6.65% | +30.53% | +94.53% | 1.85 B USD | ||
| 2056 |  AAPG Ascentage Pharma Group International - American Depository Shar | 19.65 USD | +2.13% | +8.80% | +15.52% | -21.40% | 1.83 B USD | ||
| 2071 |  ZYME Zymeworks Inc. - Common Stock | 24.80 USD | +0.57% | -5.78% | +6.44% | +39.80% | 1.81 B USD | ||
| 2076 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.38 USD | +1.20% | -7.40% | +3.36% | -36.11% | 1.79 B USD |
Frequently asked questions about Stoke Therapeutics, Inc. - Common Stock
What is the Stoke Therapeutics, Inc. - Common Stock stock price today?
The current price of Stoke Therapeutics, Inc. - Common Stock (STOK) is 29.5. Over the past 24 hours, the stock has changed by +1.27%. Follow the STOK chart for real-time price dynamics.
What is the stock ticker of Stoke Therapeutics, Inc. - Common Stock?
Stoke Therapeutics, Inc. - Common Stock trades under the ticker STOK. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Stoke Therapeutics, Inc. - Common Stock stock going up?
STOK has changed by -6.97% over the last week, -2.74% over the last month, and +149.37% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Stoke Therapeutics, Inc. - Common Stock net income for the last quarter?
Stoke Therapeutics, Inc. - Common Stock reported net income of -50 M for the last quarter. The previous quarter showed -57.93 M, which means net income changed by +13.69%.
How many employees does Stoke Therapeutics, Inc. - Common Stock have?
As of the latest available data, Stoke Therapeutics, Inc. - Common Stock has 170 employees. Workforce size can provide additional context about the company's scale and operations.
What is Stoke Therapeutics, Inc. - Common Stock EBITDA?
Stoke Therapeutics, Inc. - Common Stock EBITDA is -52.98 M, and its EBITDA margin is -850.52%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Stoke Therapeutics, Inc. - Common Stock stock?
You can buy Stoke Therapeutics, Inc. - Common Stock (STOK) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Stoke Therapeutics, Inc. - Common Stock stock?
Investing in Stoke Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the STOK chart and related analysis on metatrader.com as part of your research.